Kaiser Permanente Withheld Postpartum Treatment From Some Patients
July 12, 2021
21 min
Full
741 of 3,393
July 12, 2021
Kaiser Permanente Withheld Postpartum Treatment From Some Patients
0:00 / 21:15
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
America the Jesuit Review Episodes Around July 12, 2021
Episode 741 of 3,393 — walk the feed in the order it was published.
21:15This episodeKaiser Permanente Withheld Postpartum Treatment From Some Patients
Summary
A recent KQED report found that Kaiser Permanente, the largest health insurer in California, impeded some patients from accessing brexanolone, the first and only drug approved by the U.S. Food and Drug Administration to treat postpartum depression. The condition, affecting one in eight new mothers in California, can harm parents and children if left untreated. KQED reporter April Dembosky joins us to discuss her reporting and the challenges parents face in receiving treatment for postpartum depression.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.